Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells and use thereof

Cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells and use thereof

US Patent 11920161 · Granted Mar 5, 2024

Estimated economic value: $240,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Intratumoral vein-formation promoting agent2025
Cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells2025
Cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells2025
Cell populations of CD31-positive, CD45-negative, CD200-positive mammalian cells2025
Heterocyclic compound and use thereof2024
Lysophosphatidic acid derivative2023
Aromatic compound2021
Leukocyte infiltration promoting agent and antitumor immunostimulatory agent2021
Leukocyte infiltration promoting agent and antitumor immunostimulatory agent2021
Substituted cyclyl-acetic acid derivatives for the treatment of metabolic disord2021
Aromatic compounds with GPR40 agonistic activity2017
Spiro azetidine isoxazole derivatives and their use as SSTR antagonists2017